L.R. Caley

Elexacaftor-Tezacaftor-Ivacaftor Treatment Reduces Abdominal Symptoms in Cystic Fibrosis-Early results Obtained With the CF-Specific CFAbd-Score

Jochen G. Mainz, Carlos Zagoya, Louise Polte et al. · Frontiers in Pharmacology · 2022 · 85 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Body mass index and nutritional intake following Elexacaftor/Tezacaftor/Ivacaftor modulator therapy in adults with cystic fibrosis

L.R. Caley, Heledd Jarosz-Griffiths, Lesley Smith et al. · Journal of Cystic Fibrosis · 2023 · 37 citations · Full text

Agriculture, Nutrition, Nutritional Sciences +16

Butyrate regulates neutrophil homeostasis and impairs early antimicrobial activity in the lung

Anh Thu Dang, Christina Begka, Céline Pattaroni et al. · Mucosal Immunology · 2023 · 35 citations · Full text

Life Sciences, Immunology, Microbiology +17

Average rate of lung function decline in adults with cystic fibrosis in the United Kingdom: Data from the UK CF registry

L.R. Caley, Lesley Smith, H. White et al. · Journal of Cystic Fibrosis · 2020 · 33 citations

Health Professions, Health Sciences, Epidemiology +13

The FOCCUS study: a prospective evaluation of the frequency, severity and treatable causes of gastrointestinal symptoms during and after chemotherapy

Jervoise Andreyev, Amyn Lalji, Kabir Mohammed et al. · Supportive Care in Cancer · 2020 · 21 citations · Full text

Medicine, Oncology, Chemotherapy +8